2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Paget's Disease of the Bone: new trials by email Literature Review of Paget's Disease of the Bone trials Research Report on Paget's Disease of the Bone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Re-treatment of Participants With Paget's Disease Using Zoledronic Acid Zoledronic Acid - Paget's Disease of the Bone | Phase 4 | Completed | Novartis Pharmaceuticals | 6 | 2008-10-21 | 2021-05-26 |
| Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast® Reclast (ZOL446, zoledronic acid), Calcium, Vitamin D - Paget's Disease of the Bone, Hypocalcemia | Phase 4 | Completed | Novartis Pharmaceuticals | 81 | 2008-05-01 | 2015-03-06 |
Osteitis Deformans (2) · Hypocalcemia (1)
Bone Diseases (2) · Musculoskeletal Diseases (2) · Calcium Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Water-Electrolyte Imbalance (1)
Zoledronic Acid (2) · Calcium (1) · Vitamin D (1)
Belgium (1) · Canada (1) · New Zealand (1) · South Africa (1) · Spain (1) · United Kingdom (1) · United States (1)
2008 (1)